| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0002-9343(03)00259-6 |
| P698 | PubMed publication ID | 12893400 |
| P50 | author | Kelly Lyons | Q67211247 |
| Rajesh Pahwa | Q64857746 | ||
| P2860 | cites work | Abductor laryngeal dystonia: a series treated with botulinum toxin | Q67750311 |
| Treatment of essential tremor with arotinolol | Q69022567 | ||
| Dose-response relationship of propranolol in the treatment of essential tremor | Q69993565 | ||
| Nadolol in essential tremor | Q70271604 | ||
| A double-blind trial of clonazepam in benign essential tremor | Q70331166 | ||
| Atenolol vs. propranolol in essential tremor. A controlled, quantitative study | Q70532030 | ||
| A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor | Q71301123 | ||
| Focal task-specific tremors | Q71769900 | ||
| Botulinum toxin treatment of essential head tremor | Q72173938 | ||
| Essential tremor frequency decreases with time | Q73230760 | ||
| Botulinum toxin injections for essential voice tremor | Q73470954 | ||
| New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide | Q73709496 | ||
| Ethnic differences in essential tremor | Q73801584 | ||
| Case of essential palatal tremor: atypical features and remarkable benefit from botulinum toxin injection | Q74300605 | ||
| Arm tremor in cervical dystonia differs from essential tremor and can be classified by onset age and spread of symptoms | Q74424559 | ||
| Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology | Q74844791 | ||
| A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor | Q77310677 | ||
| Treatment of hereditary trembling chin with botulinum toxin | Q77357973 | ||
| Evidence that a gene for essential tremor maps to chromosome 2p in four families | Q77596734 | ||
| Tremor in chronic alcoholism | Q93637635 | ||
| Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor | Q28141591 | ||
| Mapping of a familial essential tremor gene, FET1, to chromosome 3q13 | Q28248376 | ||
| A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis | Q33621836 | ||
| Propranolol and propranolol-LA in essential tremor: a double blind comparative study | Q33630641 | ||
| Significance of parkinsonian manifestations in essential tremor | Q34061360 | ||
| The pathophysiology of tremor | Q34255674 | ||
| The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study | Q34377741 | ||
| Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis. | Q34643972 | ||
| Efficacy of primidone in essential tremor | Q34694632 | ||
| Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor | Q34732265 | ||
| Essential tremor: a heterogenous disorder | Q34811926 | ||
| beta-Adrenoreceptor antagonists in essential tremor | Q36995270 | ||
| Effects of timolol and atenolol on benign essential tremor: placebo-controlled studies based on quantitative tremor recording | Q37013059 | ||
| Metoprolol and propranolol in essential tremor: a double-blind, controlled study | Q37014516 | ||
| Classification of tremors | Q41146053 | ||
| How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world | Q41695134 | ||
| A summary of mechanistic hypotheses of gabapentin pharmacology | Q41743616 | ||
| Effect of a single oral dose of propranolol on essential tremor: A double-blind controlled study | Q42247226 | ||
| Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection | Q42631675 | ||
| Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. | Q42686827 | ||
| High alcoholism rate in patients with essential tremor | Q43864396 | ||
| A double-blind placebo-controlled trial of topiramate treatment for essential tremor | Q44053906 | ||
| Comparison between the effects of pindolol and propranolol on essential tremor | Q44322197 | ||
| Efficacy of alprazolam for essential tremor | Q44538692 | ||
| Long-term results of stereotaxy in the treatment of essential tremor | Q46942186 | ||
| Electrophysiological aids in distinguishing organic from psychogenic tremor | Q48444502 | ||
| High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. | Q48619185 | ||
| Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor | Q48856959 | ||
| Observations on essential (heredofamial) tremor. | Q51363299 | ||
| A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. | Q53890864 | ||
| Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. | Q53907124 | ||
| Double-blind controlled trial of gabapentin in essential tremor. | Q53951598 | ||
| OBSERVATIONS ON ESSENTIAL (HEREDOFAMILIAL) TREMOR | Q56047948 | ||
| Effect of alcohol on tremors: comparison with propranolol | Q64762168 | ||
| Alcoholism in essential tremor | Q64764611 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | essential tremor | Q693519 |
| P304 | page(s) | 134-142 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Essential tremor: differential diagnosis and current therapy | |
| P478 | volume | 115 |
| Q37952265 | A review of primary writing tremor |
| Q24187196 | Alprazolam for essential tremor |
| Q24201430 | Alprazolam for essential tremor |
| Q37029357 | Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy |
| Q24186239 | Beta blockers for essential tremor |
| Q24241056 | Beta blockers for essential tremor |
| Q37131276 | Deep brain stimulation and tremor |
| Q92760444 | Deletion of Class II ADP-Ribosylation Factors in Mice Causes Tremor by the Nav1.6 Loss in Cerebellar Purkinje Cell Axon Initial Segments |
| Q52568192 | Development of Harmaline-induced Tremor in a Swine Model. |
| Q38685853 | Functional lesional neurosurgery for tremor-a protocol for a systematic review and meta-analysis |
| Q42112489 | Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. |
| Q37691892 | Investigation of deep brain stimulation mechanisms during implantable pulse generator replacement surgery |
| Q37195047 | Management of neurologic disorders of the larynx |
| Q47794114 | Management of tremor in medieval Persia. |
| Q36082064 | Pharmacological treatment of disabling tremor |
| Q37322233 | Pharmacotherapy of essential tremor : an overview of existing and upcoming agents |
| Q24203614 | Pregabalin for essential tremor |
| Q38986127 | Pregabalin for essential tremor. |
| Q28395100 | Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons |
| Q36563781 | Short pauses in thalamic deep brain stimulation promote tremor and neuronal bursting. |
| Q38084596 | Sustained Medication Reduction Following Unilateral VIM Thalamic Stimulation for Essential Tremor |
| Q39853047 | The effect of anchors on reliability of endoscopic tremor ratings |
| Q50262795 | The effects of TPA023, a GABAAα2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol |
| Q48316102 | The effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol |
| Q35824087 | The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. |
| Q42053037 | The use of neuromodulation for the treatment of tremor |
| Q24201606 | Topiramate for essential tremor |
| Q38836991 | Topiramate for essential tremor. |
| Q34829294 | Use of antiepileptic drugs for hyperkinetic movement disorders |
| Q24201497 | Zonisamide for essential tremor |
Search more.